시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 폐경후 골다공증 치료 시장 보고서(2025년)
Postmenopausal Osteoporosis Treatment Global Market Report 2025
상품코드 : 1824444
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,469,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,350,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,232,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

폐경후 골다공증 치료 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 133억 8,000만 달러로 성장하고, CAGR은 6.1%를 나타낼 전망입니다. 예측 기간의 성장은 건강 관리 인프라 성장, 스크리닝 프로그램 증가, 정밀의료 접근법, 골다공증 치료의 바이오시밀러, 여성 건강 프로그램의 뼈 건강, 디지털 건강 통합, 재생 의료 접근법으로 인한 것으로 예측됩니다. 예측 기간의 주요 동향에는 진단 진보, 신약 개발, 신흥 치료, 신약 개발을 위한 제휴, 인공지능 통합 등이 포함됩니다.

향후 5년간의 성장률 6.1%라고 하는 예측은 전회 예측으로부터 0.2%의 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 무역 마찰은 프랑스와 스웨덴에서 개발된 차세대 비스포스포네이트 제형 및 이중 에너지 엑스레이 흡수 측정(DEXA) 스캐너에 대한 미국의 접근을 방해하여 골절 예방 지연 및 내분비학적 비용 상승을 초래할 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

예측된 골다공증 유병률 증가는 폐경후 골다공증 치료 시장의 성장을 이끌 것으로 예측됩니다. 골다공증은 골량의 감소와 골조직의 약화를 특징으로 골절의 위험을 증가시킵니다. 폐경후 골다공증 치료는 골다공증 예방 및 관리, 골절 위험 감소, 전반적인 건강 증진에 중요한 역할을 합니다. Healthy Bones Australia의 보고에 따르면 골다공증 또는 골감소증과 관련된 골절이 2021년 17만 8,439건에서 2022년 18만 3,105건으로 증가하는 것으로 나타났으며, 효과적인 폐경후 골다공증 치료의 필요성이 강조되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

SHW
영문 목차

영문목차

Postmenopausal osteoporosis treatment refers to medical interventions and strategies aimed at managing and preventing bone loss and fractures in women after menopause. Postmenopausal osteoporosis is characterized by decreased bone density and an increased susceptibility to fractures due to hormonal changes after menopause.

The main types of drugs used in postmenopausal osteoporosis treatment include bisphosphonates, vitamin D3, estrogen agonists or antagonists, hormone replacement therapy, parathyroid hormone therapy, and others. Bisphosphonates, a class of medications, are commonly used to treat various bone-related conditions, with osteoporosis being a notable example. These medications can be administered through oral, parenteral, and other routes, and they are available through various distribution channels, including hospital pharmacies, retail pharmacies, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The postmenopausal osteoporosis treatment market research report is one of a series of new reports from The Business Research Company that provides postmenopausal osteoporosis treatment market statistics, including postmenopausal osteoporosis treatment industry global market size, regional shares, competitors with a postmenopausal osteoporosis treatment market share, detailed postmenopausal osteoporosis treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the postmenopausal osteoporosis treatment industry. This postmenopausal osteoporosis treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The postmenopausal osteoporosis treatment market size has grown steadily in recent years. It will grow from $10.1 billion in 2024 to $10.54 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to aging population, hormone replacement therapy, increased awareness, fracture risk reduction, nutritional supplements.

The postmenopausal osteoporosis treatment market size is expected to see strong growth in the next few years. It will grow to $13.38 billion in 2029 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to healthcare infrastructure growth, increased screening programs, precision medicine approaches, biosimilars in osteoporosis treatment, bone health in women's health programs, digital health integration, regenerative medicine approaches. Major trends in the forecast period include diagnostic advances, new drug development, emerging therapies, collaborations for drug development, integration of ai.

The forecast of 6.1% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. access to next-generation bisphosphonates and dual-energy X-ray absorptiometry (DEXA) scanners developed in France and Sweden, resulting in delayed fracture prevention and higher endocrinology costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The projected increase in osteoporosis prevalence is expected to drive the growth of the postmenopausal osteoporosis treatment market. Osteoporosis, characterized by reduced bone mass and weakened bone tissue, poses an increased risk of fractures. Postmenopausal osteoporosis treatment plays a crucial role in preventing or managing the condition, reducing fracture risks, and enhancing overall health outcomes. A report from Healthy Bones Australia revealed a rise in fractures related to osteoporosis or osteopenia from 178,439 in 2021 to 183,105 in 2022, emphasizing the need for effective postmenopausal osteoporosis treatments.

The rising prevalence of obesity is expected to drive the growth of the postmenopausal osteoporosis treatment market in the future. Obesity is a medical condition marked by an excessive accumulation of body fat that can negatively affect health. Treatment for postmenopausal osteoporosis is particularly beneficial for individuals with obesity, as it helps increase bone density, reduce fracture risk, strengthen bones, and improve overall bone health by slowing down bone loss. This comprehensive health management can lead to a better quality of life by decreasing the risk of fractures, which significantly impacts mobility and independence. For example, in 2023, the Outdoor Industry Association (OIA), a U.S.-based non-profit, reported a 2.3% increase in outdoor recreation participants in 2022, reaching an all-time high of 168.1 million, which constitutes 55% of the U.S. population aged six and older. Thus, the growing prevalence of obesity is fueling the expansion of the postmenopausal osteoporosis treatment market.

Product innovations are emerging as a significant trend in the postmenopausal osteoporosis treatment market. Major companies in this sector are concentrating on developing innovative products, such as parathyroid hormone, to enhance efficacy and patient adherence. They are also investigating combination therapies and personalized medicine to improve treatment outcomes. Additionally, there is a strong emphasis on long-term safety studies and patient support programs to address concerns and encourage compliance. Parathyroid hormone (PTH) is produced by the parathyroid glands and plays a crucial role in regulating calcium levels in the blood. It promotes calcium release from bones, enhances reabsorption in the kidneys, and activates vitamin D to increase intestinal calcium absorption. For example, in November 2023, Apotex Corp., a pharmaceutical company based in Canada, launched teriparatide, a recombinant parathyroid hormone that significantly boosts bone mineral density and reduces fracture risk in individuals with osteoporosis. Its anabolic effects stimulate bone formation, making it an essential treatment for high-risk patients.

Major companies in the postmenopausal osteoporosis treatment market are striving to gain a competitive edge through innovative products. Advanced bone-building medications, typically administered through injections to promote bone health and density, are a focus of development. In November 2023, Teva Pharmaceuticals Inc., a U.S-based pharmaceutical company, received FDA approval for Forteo (teriparatide injection), catering to postmenopausal women with osteoporosis at high fracture risk. The approval underscores the significance of innovative bone-building medications in treating osteoporosis in both men and women.

Major companies operating in the postmenopausal osteoporosis treatment market include Pfizer Inc., Johnson and Johnson, F. Hoffmann-La Roche AG, Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi SA, Eli Lilly and Company, Amgen Inc., Asahi Kasei Corporation, Viatris Inc., Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH, Fresenius Kabi AG, Daiichi Sankyo Company Ltd., Sun Pharmaceutical Industries Ltd., Cipla Inc., Dr.Reddys Laboratories Ltd., Hikma Pharmaceuticals PLC., Amneal Pharmaceuticals LLC, Zydus Lifesciences Ltd., Takeda Pharmaceutical Company Limited, Lupin Limited, Ligand Pharmaceuticals Incorporated, Torrent Pharmaceuticals Limited.

North America was the largest region in the postmenopausal osteoporosis treatment market in 2024. The regions covered in the postmenopausal osteoporosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the postmenopausal osteoporosis treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The postmenopausal osteoporosis treatment market consists of revenues earned by entities by providing screening and diagnosis, bone density testing, and risk assessment. The market value includes the value of related goods sold by the service provider or included within the service offering. The postmenopausal osteoporosis treatment market also includes sales of selective estrogen receptor modulators and osteoporosis drugs that are used for the treatment of postmenopausal osteoporosis. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Postmenopausal Osteoporosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on postmenopausal osteoporosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for postmenopausal osteoporosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The postmenopausal osteoporosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Postmenopausal Osteoporosis Treatment Market Characteristics

3. Postmenopausal Osteoporosis Treatment Market Trends And Strategies

4. Postmenopausal Osteoporosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Postmenopausal Osteoporosis Treatment Growth Analysis And Strategic Analysis Framework

6. Postmenopausal Osteoporosis Treatment Market Segmentation

7. Postmenopausal Osteoporosis Treatment Market Regional And Country Analysis

8. Asia-Pacific Postmenopausal Osteoporosis Treatment Market

9. China Postmenopausal Osteoporosis Treatment Market

10. India Postmenopausal Osteoporosis Treatment Market

11. Japan Postmenopausal Osteoporosis Treatment Market

12. Australia Postmenopausal Osteoporosis Treatment Market

13. Indonesia Postmenopausal Osteoporosis Treatment Market

14. South Korea Postmenopausal Osteoporosis Treatment Market

15. Western Europe Postmenopausal Osteoporosis Treatment Market

16. UK Postmenopausal Osteoporosis Treatment Market

17. Germany Postmenopausal Osteoporosis Treatment Market

18. France Postmenopausal Osteoporosis Treatment Market

19. Italy Postmenopausal Osteoporosis Treatment Market

20. Spain Postmenopausal Osteoporosis Treatment Market

21. Eastern Europe Postmenopausal Osteoporosis Treatment Market

22. Russia Postmenopausal Osteoporosis Treatment Market

23. North America Postmenopausal Osteoporosis Treatment Market

24. USA Postmenopausal Osteoporosis Treatment Market

25. Canada Postmenopausal Osteoporosis Treatment Market

26. South America Postmenopausal Osteoporosis Treatment Market

27. Brazil Postmenopausal Osteoporosis Treatment Market

28. Middle East Postmenopausal Osteoporosis Treatment Market

29. Africa Postmenopausal Osteoporosis Treatment Market

30. Postmenopausal Osteoporosis Treatment Market Competitive Landscape And Company Profiles

31. Postmenopausal Osteoporosis Treatment Market Other Major And Innovative Companies

32. Global Postmenopausal Osteoporosis Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Postmenopausal Osteoporosis Treatment Market

34. Recent Developments In The Postmenopausal Osteoporosis Treatment Market

35. Postmenopausal Osteoporosis Treatment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기